Werkgroep Cardiologische centra Nederland

VICTORION-1 PREVENT (Follow-up)

A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Effect of Inclisiran on Preventing Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
Medicine
Inclisiran
Population
ASCVD
Phase
III
Starting year
2022

Director of Study

dr. I.C.D. Westendorp (Cardioloog)
Beverwijk, Rode Kruis Ziekenhuis